67 related articles for article (PubMed ID: 22882019)
1. Glioblastoma brain tumours: estimating the time from brain tumour initiation and resolution of a patient survival anomaly after similar treatment protocols.
Murray JD
J Biol Dyn; 2012; 6 Suppl 2():118-27. PubMed ID: 22882019
[TBL] [Abstract][Full Text] [Related]
2. A mathematical model of the treatment and survival of patients with high-grade brain tumours.
Kirkby NF; Jefferies SJ; Jena R; Burnet NG
J Theor Biol; 2007 Mar; 245(1):112-24. PubMed ID: 17084863
[TBL] [Abstract][Full Text] [Related]
3. Biocomputing: numerical simulation of glioblastoma growth and comparison with conventional irradiation margins.
Bondiau PY; Konukoglu E; Clatz O; Delingette H; Frenay M; Paquis P
Phys Med; 2011 Apr; 27(2):103-8. PubMed ID: 21071253
[TBL] [Abstract][Full Text] [Related]
4. Higher glioblastoma tumour burden reduces efficacy of chemotherapeutic agents: in vitro evidence.
Ng WH; Wan GQ; Too HP
J Clin Neurosci; 2007 Mar; 14(3):261-6. PubMed ID: 17258135
[TBL] [Abstract][Full Text] [Related]
5. [Dynamic characterization of the growth of brain tumors based on image sequences of nuclear magnetic resonance].
Tracqui P; Leitner F; Esteve F
Bull Cancer; 1995 Dec; 82 Suppl 5():530s-535s. PubMed ID: 8680060
[TBL] [Abstract][Full Text] [Related]
6. A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density.
Stamatakos GS; Antipas VP; Uzunoglu NK; Dale RG
Br J Radiol; 2006 May; 79(941):389-400. PubMed ID: 16632619
[TBL] [Abstract][Full Text] [Related]
7. Pilocytic astrocytoma with neoplastic gemistocytes undergoing spontaneous transformation to glioblastoma multiforme without prior radiotherapy.
Privett BJ; Liubinas SV; Tsui A; Gonzales M; Lo P
J Clin Neurosci; 2011 May; 18(5):705-7. PubMed ID: 21349721
[TBL] [Abstract][Full Text] [Related]
8. High-dose tamoxifen treatment increases the incidence of multifocal tumor recurrences in glioblastoma patients.
Puchner MJ; Giese A; Lohmann F; Cristante L
Anticancer Res; 2004; 24(6):4195-203. PubMed ID: 15736473
[TBL] [Abstract][Full Text] [Related]
9. Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.
Joo KM; Kim J; Jin J; Kim M; Seol HJ; Muradov J; Yang H; Choi YL; Park WY; Kong DS; Lee JI; Ko YH; Woo HG; Lee J; Kim S; Nam DH
Cell Rep; 2013 Jan; 3(1):260-73. PubMed ID: 23333277
[TBL] [Abstract][Full Text] [Related]
10. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.
Grunnet ML; O'Neill A; Gilbert M; Hellman R
Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748
[TBL] [Abstract][Full Text] [Related]
11. Nothing ventured, nothing gained: Treatment of glioblastoma multiforme in the elderly.
Shaw EG
J Clin Oncol; 2004 May; 22(9):1540-1. PubMed ID: 15051758
[No Abstract] [Full Text] [Related]
12. Malignant transformation of high-grade astrocytoma associated with neurocysticercosis in a patient with Turcot syndrome.
Niizuma K; Fujimura M; Kumabe T; Tominaga T
J Clin Neurosci; 2007 Jan; 14(1):53-5. PubMed ID: 17138070
[TBL] [Abstract][Full Text] [Related]
13. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of gefitinib in recurrent glioblastoma.
Rich JN; Reardon DA; Peery T; Dowell JM; Quinn JA; Penne KL; Wikstrand CJ; Van Duyn LB; Dancey JE; McLendon RE; Kao JC; Stenzel TT; Ahmed Rasheed BK; Tourt-Uhlig SE; Herndon JE; Vredenburgh JJ; Sampson JH; Friedman AH; Bigner DD; Friedman HS
J Clin Oncol; 2004 Jan; 22(1):133-42. PubMed ID: 14638850
[TBL] [Abstract][Full Text] [Related]
15. Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles.
Wohlfart S; Khalansky AS; Bernreuther C; Michaelis M; Cinatl J; Glatzel M; Kreuter J
Int J Pharm; 2011 Aug; 415(1-2):244-51. PubMed ID: 21641983
[TBL] [Abstract][Full Text] [Related]
16. Expression of enzymes and oncogene induced after radiotherapy and/or chemotherapy in patients with brain tumors.
Yoshii Y; Saito A; Hyodo A; Tsurushima H; Sun L
Hum Cell; 2001 Mar; 14(1):95-103. PubMed ID: 11436358
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatment with 4-211Atphenylalanine enhances survival of rats with intracranial glioblastoma.
Borrmann N; Friedrich S; Schwabe K; Hedrich HJ; Krauss JK; Knapp WH; Nakamura M; Meyer GJ; Walte A
Nuklearmedizin; 2013 Dec; 52(6):212-21. PubMed ID: 24036694
[TBL] [Abstract][Full Text] [Related]
18. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
19. A mathematical model of glioma growth: the effect of chemotherapy on spatio-temporal growth.
Tracqui P; Cruywagen GC; Woodward DE; Bartoo GT; Murray JD; Alvord EC
Cell Prolif; 1995 Jan; 28(1):17-31. PubMed ID: 7833383
[TBL] [Abstract][Full Text] [Related]
20. [Glioblastomas: clinical study and search for prognostic factors].
Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
